April 3 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O:
AMNEAL ANNOUNCES EXPANDED COVERAGE FOR CREXONT® (CARBIDOPA AND LEVODOPA) TO ENHANCE ACCESS FOR PARKINSON’S DISEASE PATIENTS IN THE U.S.
Source text: ID:nBw4yQPKPa
Further company coverage: AMRX.O
(((( Reuters.briefs@thomsonreuters.com ;));))